Accessibility Statement Skip Navigation
  • Resources
  • Blog
  • Journalists
  • +44 (0)20 7454 5110
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All Public Company News
      • All Multimedia News
      • View All News Releases

      • Regulatory News

      • D/A/CH Regulatory News
      • UK Regulatory News
      • View All Regulatory News

  • Business & Money
      • Auto & Transportation

      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalisation
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defence
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers & Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines & Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics & Personal Care
      • Fashion
      • Food & Beverages
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewellery
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental
      • European Government
      • Labour & Union
      • Natural Disasters
      • Not For Profit
      • Public Safety
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Overview
  • Distribution
  • Paid Placement
  • Multichannel Amplification
  • Disclosure Services
  • SocialBoost
  • Rooms
    • MediaRoom
    • ESG Rooms
  • AI Tools
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Hamburger menu
  • Cision PR Newswire UK provides press release distribution, targeting, monitoring, and marketing services
  • Send a Release
    • Phone

    • +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT

    • ALL CONTACT INFO
    • Contact Us

      +44 (0)20 7454 5110
      from 8 AM - 5:30 PM GMT

  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • News in Focus
    • Browse News Releases
    • Regulatory News
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • Overview
  • Distribution
  • Paid Placement
  • Multichannel Amplification
  • Disclosure Services
  • Cision Communications Cloud®
  • AI Tools
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists

Varicose Vein Treatment Market to reach US$ 1,059.9 Mn by end of 2028, Says Coherent Market Insights

This image opens in the lightbox

News provided by

Coherent Market Insights

21 Dec, 2021, 18:30 GMT

Share this article

Share toX

Share this article

Share toX

SEATTLE, Dec. 21, 2021 /PRNewswire/ -- According to Coherent Market Insights, The global varicose vein treatment market is estimated to account for 1,059.9 Mn in terms of value by the end of 2028.

Varicose veins are twisted, enlarged veins caused by increased blood pressure in the veins. Medical treatment for varicose veins typically starts with medical management, including the use of compression stockings and leg elevation. Some patients will benefit from procedures, such as sclerotherapy, thermal ablation, or phlebectomy. Phlebectomy treats surface varicose veins. Very small cuts are made near the damaged vein. Sclerotherapy involves an injection of a solution (generally a salt solution) directly into the vein. The solution irritates the lining of the blood vessel, causing it to collapse and stick together and the blood to clot.

One method uses a light under the skin to guide treatment. There are risks involved in all of these procedures, and they should only be used as a last resort. For the majority of patients, however, these procedures provide excellent results and are considered an integral part of addressing varicose veins. Pregnant women may need compression stockings and pain medication. They should avoid standing for long periods of time and should keep their weight at a healthy level. Smoking is harmful to blood vessels, reducing circulation and damaging vein walls. It's also not a good idea to smoke, as smoking damages blood vessels and can lead to a variety of health problems. Exercise is essential, but avoid vigorous activity. This can worsen your condition.

Ask for Sample Copy of this Report @ https://www.coherentmarketinsights.com/insight/request-sample/246

Market Drivers:

High prevalence of varicose vein is expected to propel growth of the global varicose vein treatment market over the forecast period. For instance, the prevalence of varicosities formation was noted high in the Northern Indian population with around one-third of women (in the study group) and one fifth of men found affected by this disorder, according to a study published in 2019 in Research & Reviews: A Journal of Health Professions.

Moreover, increasing geriatric population is also expected to propel growth of the global varicose vein treatment market over the forecast period. For instance, according to the World Health Organization, geriatric population is expected to reach 2 billion by 2050, up from 900 million in 2015.

Market Opportunities:

Regional expansion is expected to offer lucrative growth opportunities for players in the global varicose veins treatment market. For instance, in November 2021, THERACLION, a company focused on the development of scalable robotic platforms for non-invasive echotherapy, completed the first varicose veins echotherapy treatment in China.

Moreover, venture funding is also expected to offer lucrative growth opportunities for players in the global varicose veins treatment market. For instance, in December 2021, Pristyn Care raised over US$ 85 million in Series E funding. The company performs surgeries for over 50 diseases such as piles, gynecology, phimosis, varicose veins, DVT, hernia, sinus, gallstones, and cataract. 

Market Trends:

North America is expected to witness significant growth in the global varicose veins treatment market, owing to high prevalence of varicose veins in the region. For instance, over 40 million people in the U.S. suffer from varicose veins, according to the American Vein and Lymphatic Society (2019).

Major players operating in the global varicose veins treatment market are focused on adopting merger and acquisition strategies to expand their product portfolio. For instance, in December 2021, BD announced to acquire Venclose, a catheter-therapy developer, to enter a new market for its venous therapy portfolio with treatments for varicose veins.

Request for Customization @ https://www.coherentmarketinsights.com/insight/request-customization/246

Competitive Landscape:

Major players operating in the global varicose veins treatment market include, AngioDynamics, Inc., Alma Lasers Ltd., Alna-Medicalsystem GmbH, Dornier Medtech GmbH, Energist Ltd., Intros Medical Laser GmbH, LSO Medical, Syneron Medical Ltd., and WONTECH Co., Ltd.

Market Segmentation:

  • Varicose Veins Treatment Market, By Product Type:
      • Endovenous Laser Systems
        • Diode Lasers
        • Yag Lasers
      • Endovenous Laser Fibers
        • Bare Tip Laser Fiber
        • Radial Tip Laser Fiber
        • Gold tip Laser Fiber
      • Treatment Method
        • Non-thermal Ablation
        • Radiofrequency Ablation
        • Sclerotherapy
  • Varicose Veins Treatment Market, By End User:
    • Hospitals
    • Ambulatory Surgical Centers
    • Specialized Clinics

Global Varicose Veins Treatment Market, By Region:

    • North America
      • By Country:
        • U.S.
        • Canada
    • Europe
      • By Country
        • U.K.
        • Germany
        • Italy
        • France
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • By Country
        • China
        • India
        • Japan
        • ASEAN
        • Australia
        • South Korea
        • Rest of Asia Pacific
    • Latin America
      • By Country
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Middle East & Africa
      • By Country:
        • GCC Countries
        • Israel
        • South Africa
        • Rest of Middle East & Africa

Christmas Sale is Live Now! Get 25 to 30% of Big Discount till 31st Dec 2021. Buy this Complete Report Now @ https://www.coherentmarketinsights.com/insight/buy-now/246 

Find more trending reports below:

Hemorrhoid Treatment Devices Market By Product Type (Rubber Band Ligators, Sclerotherapy Injections, Cryotherapy Devices, Infrared Coagulators, Laser Probes, Bipolar Probes, and Others), By End-users (Hospitals and Clinics, Ambulatory Surgery Centers, and Others), and by Region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2019 – 2026

Uterine Fibroid Treatment Devices Market by Technology Type (Surgical Technique (Hysterectomy and Myomectomy) Laparoscopic techniques (Laparoscopic Myomectomy and Myolysis) Ablation Techniques (Microwave Ablation, Cryoablation, and Ultrasound Ablation (High Intensity Focused Ultrasound (HIFU) and MRI-guided Focused Ultrasound (MRgFUS)) Other Ablation Techniques) Embolization Techniques) by Mode of Treatment (Invasive Treatment, Minimally Invasive Treatment, and Non-Invasive Treatment) By End User (Hospitals, Clinics, and Ambulatory Surgical Center)- Size, Share, Outlook, and Opportunity Analysis, 2018 – 2026

Urinary Incontinence Treatment Devices Market, by Product (Urinary Catheters, Electrical Stimulation Devices, Artificial Urinary Sphincters, Wearable Devices, Slings (Male Slings and Female Slings), and Other Devices), by Category (Internal Urinary Incontinence Devices and External Urinary Incontinence Devices), by Incontinence (Stress Incontinence, Urge Incontinence, Overflow Incontinence, and Functional Incontinence), by End User (Clinics, Hospitals, Ambulatory surgical centers, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) – Size, Share, Outlook, and Opportunity Analysis, 2019–2026

About Us:

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having sales office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 57 countries worldwide. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.

Contact Us:

Mr. Shah
Senior Client Partner – Business Development
Coherent Market Insights
Phone:
US: +1-206-701-6702
UK: +44-020-8133-4027
Japan: +81-050-5539-1737
India: +91-848-285-0837
Email: sales@coherentmarketinsights.com
Website: https://www.coherentmarketinsights.com
Follow Us:
 LinkedIn | Twitter

Logo: https://mma.prnewswire.com/media/902389/Coherent_Market_Insights_Logo.jpg

Modal title

Also from this source

Global Cardiovascular Health Supplements Market worth $16.06 billion by 2030, Exclusive Report by Coherent Market Insights

Global Cardiovascular Health Supplements Market worth $16.06 billion by 2030, Exclusive Report by Coherent Market Insights

The global Cardiovascular Health Supplements Market is estimated to be valued at US$ 9.85 Bn in 2023 and is expected to exhibit a CAGR of 7.2% over...

Global Glucose Biosensor Market Size to hit $21.3 billion by 2031, growing at a CAGR of 7.7%, says Coherent Market Insights

Global Glucose Biosensor Market Size to hit $21.3 billion by 2031, growing at a CAGR of 7.7%, says Coherent Market Insights

The global Glucose Biosensor Market is projected to grow from USD 11.77 billion in 2023 to USD 21.3 billion by 2031, with a compound annual growth...

More Releases From This Source

Explore

Medical Pharmaceuticals

Medical Pharmaceuticals

Health Care & Hospitals

Health Care & Hospitals

News Releases in Similar Topics

Contact PR Newswire

  • +44 (0)20 7454 5110
    from 8 AM - 5:30 PM GMT
  • General Enquiries
  • Media Enquiries
  • Partnerships

Products

  • Content Distribution
  • Multimedia Services
  • Disclosure Services
  • Cision Communications Cloud®

About

  • About PR Newswire
  • About Cision
  • Partnering Opportunities
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United States
  • Vietnam

My Services

  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
  • Data Privacy

Do not sell or share my personal information:

  • Submit via Privacy@cision.com 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
+44 (0)20 7454 5110
from 8 AM - 5:30 PM GMT
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 PR Newswire Europe Limited. All Rights Reserved. A Cision company.